General Electric Company (ETR:GCP)

Marinus Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	249,986	174,360	125,673	85,668	91,180	77,341
Market Cap Growth	43.91%	38.74%	46.70%	-6.05%	17.89%	-10.95%
Enterprise Value	257,485	179,894	130,988	102,511	132,144	128,597
Last Close Price	236.00	160.46	114.84	46.96	64.04	49.77
PE Ratio	37.85	27.53	15.12	1795.19	-	18.68
PS Ratio	7.06	4.66	3.93	3.14	1.84	1.25
PB Ratio	15.18	9.23	4.86	2.62	2.49	2.55
P/TBV Ratio	50.68	27.57	10.06	6.28	21.64	269.54
P/FCF Ratio	-	49.08	32.10	17.42	43.79	47.57
P/OCF Ratio	-	38.33	26.77	15.47	29.79	26.52
EV/Sales Ratio	7.22	4.81	4.10	3.76	2.66	2.07
EV/EBITDA Ratio	27.33	20.83	19.50	21.21	65.63	55.55
EV/EBIT Ratio	32.20	24.01	23.18	27.52	-	-
EV/FCF Ratio	55.06	50.64	33.46	20.85	63.46	79.09
Debt / Equity Ratio	1.03	1.04	0.76	0.75	0.91	2.11
Debt / EBITDA Ratio	1.85	2.16	2.74	4.59	11.97	19.49
Debt / FCF Ratio	3.64	5.54	5.03	4.98	16.06	39.26
Asset Turnover	0.34	0.26	0.20	0.15	0.25	0.29
Inventory Turnover	2.49	2.69	1.98	1.23	2.71	3.46
Quick Ratio	0.68	0.77	1.01	0.82	0.93	1.20
Current Ratio	1.04	1.09	1.33	1.18	1.28	1.55
Return on Equity (ROE)	39.57%	27.64%	29.75%	3.53%	-12.55%	19.29%
Return on Assets (ROA)	4.61%	3.27%	2.16%	1.28%	-0.02%	-0.15%
Return on Capital (ROIC)	14.49%	10.74%	7.00%	3.54%	-0.04%	-0.33%
Return on Capital Employed (ROCE)	10.30%	8.70%	4.40%	2.90%	-	-
Earnings Yield	2.64%	3.63%	6.83%	0.37%	-6.11%	6.03%
FCF Yield	1.87%	2.04%	3.12%	5.74%	2.28%	2.10%
Dividend Yield	0.50%	0.67%	0.25%	0.64%	0.44%	0.53%
Payout Ratio	16.78%	15.38%	6.21%	190.18%	-	11.36%
Buyback Yield / Dilution	1.77%	0.46%	0.18%	-0.27%	-0.27%	-0.37%
Total Shareholder Return	2.27%	1.13%	0.43%	0.36%	0.17%	0.16%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.